Note that IPIX is not OBLIGATED to sell 30 million to
Note that IPIX is not OBLIGATED to sell 30 million to Aspire, they just have the option to do so if they want to.
Totally agree that this is helpful for their negotiations. If a Big Pharma thinks that IPIX is desperate, they will offer a crap deal. If they know that IPIX can walk away and stay in business.... they're going to have to negotiate more honestly.
I have said all along that I thought that some Big Pharma might be involved in the Mako take-down action (using them as a front). We KNOW that 1 or possibly 2 Swiss pharmaceutical giants have been involved in such actions in the past.
Also, please note that Mr. Ehrlich refers to Aspire as an institutional investor. Hopefully that will put to rest the absurd basher lie that Aspire's business plan is to buy IPIX stock, then immediately turn around and sell if for a loss.
I view this as a very positive move. IPIX is saying: make a deal with us if you want to offer us a fair one, but if you don't, fine, we have other investors and we'll just keep developing our drugs.
MUCH better than being in a desperate situation, which is what the bashers have hoped for.
7
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Gearing Up for September: MongoDB Targets Investors Folks in the investing world, circle some dates on your calendars. MongoDB, Inc. (NASDAQ: MDB) is taking the stage at three separate investor conferences this September. Why should we care? Because these are not just any old gigs—it's big names like Citi, Goldman Sachs, and Piper Sandler, and they happen to be perfect...
Continue Reading
Revolutionizing AI Software with a New Approach If there's one thing the tech industry loves, it's a fresh model promising to streamline project chaos into well-oiled machinery. Enter Proxet with what they're calling the IDLC model—that's Intent-Driven Lifecycle. It's aimed straight at the creaky old way companies have been handling AI and software projects. The idea is...
Continue Reading
Legal Storm Brewing with AEVEX's IPO Disclosures Whatever happened to straightforward honesty in business? AEVEX Corp. (NYSE: AVEX) might have forgotten that chapter judging by fresh allegations in their midst. Investors who bought AVEX Class A common stock between April 17 and June 4, 2026, have been hit with a curveball: a looming class action lawsuit for securities...
Continue Reading
Cars, Community, and Cause Today’s dialogue isn’t about upcoming IPOs or blue-chip stocks, it's about classic cars rolling into the spotlight for something bigger than horsepower or polish. On Sunday, September 27, from noon till three, Dynamic Automotive will host its 18th Annual Car Show in Urbana, Maryland. They’re not just showing off vintage steel; they’re...
Continue Reading
AI-Powered Revolution in Credit Disputes Alright, here we are staring down the latest twist in the credit game. CreditRefresh, an AI-driven platform out of Dover, Delaware, has managed to kickstart its journey by challenging over 1,000 credit report errors in just its first month on the market. That's quite a sprint straight from the gate, don't you think? But hey, this...
Continue Reading
Changing the Game with a New Chief People Officer There’s an old saying in retail: talent rules everything. Well, Exemplar Luxury Group is doubling down on this with its appointment of Gretchen Koback Pursel as Chief People Officer. Set to take the reins on September 28, Pursel brings an impressive resume chock-full of luxury and innovative transformations from big...
Continue Reading
Local Impact Means Taking Climate Change Personally If you haven't felt it yet, you will. Climate change isn't just a global headline anymore—it's a daily reality that’s reshaping life where you stand. David W. DuBois, New Mexico's top climatologist, is sounding the alarm this time on the new Net Zero Speaks episode, saying it's on us to use local climate knowledge to...
Continue Reading
Who Knew? Design Awards Aren't Just for Pretty Pictures TrailBlazer Magazine gets a pat on the back from GDUSA's 2026 Inhouse Design Awards, a nod to top-notch design work. With over 4,000 entries across the board, getting into the top 10 percent is like finding a steakhouse with zero line on a Friday night. Not exactly common, right? Design Worth Cheering For The winning...
Continue Reading
Breathing New Life into Clinical Trials Alright, folks, listen up. We've got a fresh collaboration cooking that could shake things up in the clinical trial sector. Signant Health, a heavyweight in clinical trial solutions, has teamed up with Lothar Medical, and they’ve hitched their wagons to launch something rather intriguing: the ALDS PRO pulmonary function tech. Let...
Continue Reading
Cracking the Future: AEON Introduces Agentic Checkout There's a new sheriff in the AI economy: AEON, throwing its hat in the ring with the debut of Agentic Checkout. Now if you think we're just talking about basic automation here, think again. This thing's got its own AI Card that transforms your shopping commands into planned purchases. Think of it as handing over your...
Continue Reading
Top 5 Most Recently Viewed Articles
Vantage Foundation Spreads Holiday Cheer The Vantage Foundation has taken a significant step in supporting children and families in challenging situations through a heartwarming collaboration with Team Building with Purpose. This partnership facilitated a corporate volunteering session benefiting the Starlight Children's Foundation Sydney, dedicated to brightening the...
Continue Reading
Overview of Ascot Resources Ltd. Ascot Resources Ltd. is a dynamic Canadian mining firm headquartered in Vancouver, known for its operations in the Golden Triangle region of British Columbia. The company's shares are traded on the Toronto Stock Exchange under the ticker TSX: AOT and on the OTCQB as OTCQB: AOTVF. With a strong commitment to responsible mining, Ascot is...
Continue Reading
Bank of America Announces Quarterly Dividends Bank of America Corporation (NYSE: BAC) has recently declared its quarterly cash dividends for both common and preferred stockholders. For common stock, the dividend is set at $0.26 per share, while the 7% Cumulative Redeemable Preferred Stock, Series B, will see a regular quarterly cash dividend of $1.75 per share. These...
Continue Reading
Hedge Funds Tackle Market Challenges in August Despite the ups and downs in the financial markets throughout August, hedge funds managed to secure impressive gains. Reports reveal that global hedge funds achieved an average return of 1.3% for the month, highlighting their resilience in the face of changing market conditions. Market Reactions and Strategies The month...
Continue Reading
Lennox Strengthens Customer Experience and Network The essential investments by Lennox are set to enhance customer service and training capabilities while expanding distribution infrastructure significantly. The firm, a leader in the HVAC industry, is investing in its operations to provide superior service for its clients. Key Investments in Infrastructure Lennox is...
Continue Reading